| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |